Notes - Segment Information, Etc.

Carna Biosciences, Inc. - Filing #7345290

Concept 2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2023-01-01 to
2023-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
Notes - Segment information, etc.
Segment information
Disclosure of sales, profit (loss), asset, liability, and other items for each reportable segment
Sales
Revenues from external customers
1,625,889,000 JPY
918,239,000 JPY
1,625,889,000 JPY
707,650,000 JPY
JPY
1,100,703,000 JPY
JPY
1,386,748,000 JPY
1,386,748,000 JPY
286,045,000 JPY
Transactions with other segments
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Other items
Depreciation
35,612,000 JPY
23,298,000 JPY
35,612,000 JPY
12,313,000 JPY
JPY
21,061,000 JPY
JPY
33,808,000 JPY
33,808,000 JPY
12,746,000 JPY
Increase in property, plant and equipment and intangible assets
44,550,000 JPY
39,369,000 JPY
44,550,000 JPY
5,180,000 JPY
JPY
57,508,000 JPY
JPY
126,001,000 JPY
126,001,000 JPY
68,492,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.